Intradermal delivery of substances

    公开(公告)号:US08986280B2

    公开(公告)日:2015-03-24

    申请号:US13866425

    申请日:2013-04-19

    摘要: The present invention provides improved methods for ID delivery of drugs and other substances to humans or animals. The methods employ small gauge needles, especially microneedles, placed in the intradermal space to deliver the substance to the intradermal space as a bolus or by infusion. It has been discovered that the placement of the needle outlet within the skin and the exposed height of the needle outlet are critical for efficacious delivery of active substances via small gauge needles to prevent leakage of the substance out of the skin and to improve absorption within the intradermal space. The pharmacokinetics of hormone drugs delivered according to the methods of the invention have been found to be very similar to the pharmacokinetics of conventional SC delivery, indicating that ID administration according to the methods of the invention is likely to produce a similar clinical result (i.e., similar efficacy) with the advantage of reduction or elimination of pain for the patient. Delivery devices which place the needle outlet at an appropriate depth in the intradermal space and control the volume and rate of fluid delivery provide accurate delivery of the substance to the desired location without leakage.

    INTRADERMAL DELIVERY OF SUBSTANCES

    公开(公告)号:US20130237960A1

    公开(公告)日:2013-09-12

    申请号:US13866425

    申请日:2013-04-19

    IPC分类号: A61M5/46 A61M37/00

    摘要: The present invention provides improved methods for ID delivery of drugs and other substances to humans or animals. The methods employ small gauge needles, especially microneedles, placed in the intradermal space to deliver the substance to the intradermal space as a bolus or by infusion. It has been discovered that the placement of the needle outlet within the skin and the exposed height of the needle outlet are critical for efficacious delivery of active substances via small gauge needles to prevent leakage of the substance out of the skin and to improve absorption within the intradermal space. The pharmacokinetics of hormone drugs delivered according to the methods of the invention have been found to be very similar to the pharmacokinetics of conventional SC delivery, indicating that ID administration according to the methods of the invention is likely to produce a similar clinical result (i.e., similar efficacy) with the advantage of reduction or elimination of pain for the patient. Delivery devices which place the needle outlet at an appropriate depth in the intradermal space and control the volume and rate of fluid delivery provide accurate delivery of the substance to the desired location without leakage.

    INTRADERMAL DELIVERY OF SUBSTANCES

    公开(公告)号:US20130245601A1

    公开(公告)日:2013-09-19

    申请号:US13866381

    申请日:2013-04-19

    IPC分类号: A61M5/158

    摘要: The present invention provides improved methods for ID delivery of drugs and other substances to humans or animals. The methods employ small gauge needles, especially microneedles, placed in the intradermal space to deliver the substance to the intradermal space as a bolus or by infusion. It has been discovered that the placement of the needle outlet within the skin and the exposed height of the needle outlet are critical for efficacious delivery of active substances via small gauge needles to prevent leakage of the substance out of the skin and to improve absorption within the intradermal space. The pharmacokinetics of hormone drugs delivered according to the methods of the invention have been found to be very similar to the pharmacokinetics of conventional SC delivery, indicating that ID administration according to the methods of the invention is likely to produce a similar clinical result (i.e., similar efficacy) with the advantage of reduction or elimination of pain for the patient. Delivery devices which place the needle outlet at an appropriate depth in the intradermal space and control the volume and rate of fluid delivery provide accurate delivery of the substance to the desired location without leakage.

    Intradermal delivery of substances
    7.
    发明授权
    Intradermal delivery of substances 有权
    物质的皮内递送

    公开(公告)号:US08998877B2

    公开(公告)日:2015-04-07

    申请号:US13866446

    申请日:2013-04-19

    摘要: The present invention provides improved methods for ID delivery of drugs and other substances to humans or animals. The methods employ small gauge needles, especially microneedles, placed in the intradermal space to deliver the substance to the intradermal space as a bolus or by infusion. It has been discovered that the placement of the needle outlet within the skin and the exposed height of the needle outlet are critical for efficacious delivery of active substances via small gauge needles to prevent leakage of the substance out of the skin and to improve absorption within the intradermal space. The pharmacokinetics of hormone drugs delivered according to the methods of the invention have been found to be very similar to the pharmacokinetics of conventional SC delivery, indicating that ID administration according to the methods of the invention is likely to produce a similar clinical result (i.e., similar efficacy) with the advantage of reduction or elimination of pain for the patient. Delivery devices which place the needle outlet at an appropriate depth in the intradermal space and control the volume and rate of fluid delivery provide accurate delivery of the substance to the desired location without leakage.

    摘要翻译: 本发明提供了将药物和其它物质的ID递送给人或动物的改进方法。 该方法使用放置在皮内空间中的小规格针,特别是微针,以将物质作为推注或通过输注递送至皮内空间。 已经发现,针出口在皮肤内的放置和针出口的暴露高度对于通过小规格针有效递送活性物质是至关重要的,以防止物质从皮肤泄漏并改善吸收在 皮内空间。 已经发现根据本发明的方法递送的激素药物的药代动力学与常规SC递送的药代动力学非常相似,表明根据本发明的方法的ID给药可能产生类似的临床结果(即, 具有类似功效),具有减少或消除患者疼痛的优点。 将针头出口放置在皮内空间内的适当深度并控制流体输送的体积和速率的输送装置能够将物质精确地输送到期望的位置而不泄漏。

    Intradermal delivery of substances

    公开(公告)号:US09005182B2

    公开(公告)日:2015-04-14

    申请号:US13866381

    申请日:2013-04-19

    摘要: The present invention provides improved methods for ID delivery of drugs and other substances to humans or animals. The methods employ small gauge needles, especially microneedles, placed in the intradermal space to deliver the substance to the intradermal space as a bolus or by infusion. It has been discovered that the placement of the needle outlet within the skin and the exposed height of the needle outlet are critical for efficacious delivery of active substances via small gauge needles to prevent leakage of the substance out of the skin and to improve absorption within the intradermal space. The pharmacokinetics of hormone drugs delivered according to the methods of the invention have been found to be very similar to the pharmacokinetics of conventional SC delivery, indicating that ID administration according to the methods of the invention is likely to produce a similar clinical result (i.e., similar efficacy) with the advantage of reduction or elimination of pain for the patient. Delivery devices which place the needle outlet at an appropriate depth in the intradermal space and control the volume and rate of fluid delivery provide accurate delivery of the substance to the desired location without leakage.

    INTRADERMAL DELIVERY OF SUBSTANCES
    9.
    发明申请
    INTRADERMAL DELIVERY OF SUBSTANCES 审中-公开
    物质输送

    公开(公告)号:US20130237961A1

    公开(公告)日:2013-09-12

    申请号:US13866446

    申请日:2013-04-19

    IPC分类号: A61M5/158

    摘要: The present invention provides improved methods for ID delivery of drugs and other substances to humans or animals. The methods employ small gauge needles, especially microneedles, placed in the intradermal space to delver the substance to the intradermal space as a bolus or by infusion. It has been discovered that the placement of the needle outlet within the skin and the exposed height of the needle outlet are critical for efficacious delivery of active substances via small gauge needles to prevent leakage of the substance out of the skin and to improve absorption within the intradermal space. The pharmacokinetics of hormone drugs delivered according to the methods of the invention have been found to be very similar to the pharmacokinetics of conventional SC delivery, indicating that ID administration according to the methods of the invention is likely to produce a similar clinical result (i.e., similar efficacy) with the advantage of reduction or elimination of pain for the patient. Delivery devices which place the needle outlet at an appropriate depth in the intradermal space and control the volume and rate of fluid delivery provide accurate delivery of the substance to the desired location without leakage.

    摘要翻译: 本发明提供了将药物和其它物质的ID递送给人或动物的改进方法。 该方法使用小规格针,特别是微针,放置在皮内空间中,以将物质作为推注或通过输注将物质移入皮内空间。 已经发现,针出口在皮肤内的放置和针出口的暴露高度对于通过小规格针有效递送活性物质是至关重要的,以防止物质从皮肤泄漏并改善吸收在 皮内空间。 已经发现根据本发明的方法递送的激素药物的药代动力学与常规SC递送的药代动力学非常相似,表明根据本发明的方法的ID给药可能产生类似的临床结果(即, 具有类似功效),具有减少或消除患者疼痛的优点。 将针头出口放置在皮内空间内的适当深度并控制流体输送的体积和速率的输送装置能够将物质精确地输送到期望的位置而不泄漏。